GR3005682T3 - - Google Patents

Info

Publication number
GR3005682T3
GR3005682T3 GR920402010T GR920402010T GR3005682T3 GR 3005682 T3 GR3005682 T3 GR 3005682T3 GR 920402010 T GR920402010 T GR 920402010T GR 920402010 T GR920402010 T GR 920402010T GR 3005682 T3 GR3005682 T3 GR 3005682T3
Authority
GR
Greece
Prior art keywords
methyl
carbazol
imidazol
solvates
tetrahydro
Prior art date
Application number
GR920402010T
Other languages
Greek (el)
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GR3005682T3 publication Critical patent/GR3005682T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Emergency Protection Circuit Devices (AREA)
  • Connection Of Batteries Or Terminals (AREA)
  • Saccharide Compounds (AREA)
  • Electrotherapy Devices (AREA)
GR920402010T 1986-12-17 1992-09-10 GR3005682T3 (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868630071A GB8630071D0 (en) 1986-12-17 1986-12-17 Medicaments

Publications (1)

Publication Number Publication Date
GR3005682T3 true GR3005682T3 (enExample) 1993-06-07

Family

ID=10609112

Family Applications (1)

Application Number Title Priority Date Filing Date
GR920402010T GR3005682T3 (enExample) 1986-12-17 1992-09-10

Country Status (18)

Country Link
US (1) US4835173A (enExample)
EP (1) EP0276559B1 (enExample)
JP (1) JP2732844B2 (enExample)
KR (1) KR880007073A (enExample)
AT (1) ATE79031T1 (enExample)
AU (1) AU608794B2 (enExample)
CY (1) CY1693A (enExample)
DE (1) DE3780940T2 (enExample)
DK (1) DK662787A (enExample)
ES (1) ES2051754T3 (enExample)
GB (1) GB8630071D0 (enExample)
GR (1) GR3005682T3 (enExample)
HK (1) HK36593A (enExample)
IE (1) IE60135B1 (enExample)
IL (1) IL84844A0 (enExample)
NZ (1) NZ222949A (enExample)
PH (1) PH25503A (enExample)
ZA (1) ZA879458B (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5246941A (en) * 1986-12-17 1993-09-21 Glaxo Group Limited Method for the treatment of depression
DE3788057T2 (de) * 1986-12-17 1994-03-03 Glaxo Group Ltd Verwendung von heterocyclischen Verbindungen zur Behandlung von Depressionen.
GB8820653D0 (en) * 1988-09-01 1988-10-05 Glaxo Group Ltd Medicaments
US5221687A (en) * 1988-09-01 1993-06-22 Glaxo Group Limited Medicaments
US5180728A (en) * 1989-09-25 1993-01-19 Fujisawa Pharmaceutical Company, Ltd. Pyrimidoindole derivatives and processes for preparation thereof
US5225407A (en) * 1990-02-22 1993-07-06 Glaxo Group Limited 5-HT3 receptor antagonists for the treatment of autism
JPH06508836A (ja) * 1991-06-26 1994-10-06 セプラコア，インコーポレーテッド 光学的に純粋なｒ（＋）オンダンセトロンを使用する嘔吐、吐き気および他の障害の治療のための方法および組成物
AU779696B2 (en) 1999-03-01 2005-02-10 Sepracor, Inc. Methods for treating apnea and apnea disorders using optically pure R(+)ondansetron
HUP0401239A2 (hu) * 2000-10-30 2004-12-28 Teva Pharmaceutical Industries Ltd. Ondansetron-hidroklorid új kristályos és szolvát formái, valamint eljárások az előállításukra
EP1207160A1 (en) * 2000-11-20 2002-05-22 Hanmi Pharm. Co., Ltd. Process for the preparation of 1,2,3,9-tetrahydro-9-methyl-3-((2-methyl-1H-imidazol-1-yl)-methyl)-4H-carbazol-4-one
US20020115707A1 (en) * 2001-01-11 2002-08-22 Rami Lidor-Hadas Process for preparing pure ondansetron hydrochloride dihydrate
YU56103A (sh) * 2001-01-11 2006-05-25 Teva Pharmaceutical Industries Ltd. Poboljšani postupak za pripremanje čistog ondansetron hidrohlorid dihidrata
CN1665823A (zh) * 2002-04-29 2005-09-07 特瓦药厂有限公司 制备1,2,3,9－四氢－9－甲基－3－[(2－甲基－1h－咪唑－1－基)甲基]－4h－咔唑－4－酮的方法
EP1465887A1 (en) * 2002-04-30 2004-10-13 Teva Gyogyszergyar Reszvenytarsasag Novel crystal forms of ondansetron, processes for their preparation, pharmaceutical compositions containing the novel forms and methods for treating nausea using them
US20050131045A1 (en) * 2002-04-30 2005-06-16 Judith Aronhime Novel crystal forms of ondansetron, processes for their preparation, pharmaceutical, compositions containing the novel forms and methods for treating nausea using them
HU225885B1 (en) * 2002-10-17 2007-11-28 Richter Gedeon Nyrt Process for producing ondansetron hydrochlorid dihydrate of high purity
WO2009027564A1 (es) * 2007-08-08 2009-03-05 Legarda Ibanez Juan Jose Uso y métodos de uso de un antagonista del receptor (5-ht3) de la serotonina3 y un modulador selectivo de los canales de cloruro para el tratamiento de la adicción a o la dependencia de fármacos/drogas o trastornos del sistema nervioso central
AU2019290926B2 (en) * 2018-06-21 2025-01-23 Societe Des Produits Nestle S.A. Compositions and methods using a nicotinamide adenine dinucleotide (NAD+) precursor and at least one ketone or ketone precursor

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN158970B (enExample) * 1981-06-09 1987-02-28 Ici Plc
GB8401888D0 (en) * 1984-01-25 1984-02-29 Glaxo Group Ltd Heterocyclic compounds
AT392276B (de) * 1984-01-25 1991-02-25 Glaxo Group Ltd Verfahren zur herstellung von neuen tetrahydrocarbazol-derivaten
DE385517T1 (de) * 1985-03-14 1991-07-25 Beecham Group p.l.c., Brentford, Middlesex Arzneimittel zur behandlung von erbrechen.
GB8516083D0 (en) * 1985-06-25 1985-07-31 Glaxo Group Ltd Heterocyclic compounds
GB8518743D0 (en) * 1985-07-24 1985-08-29 Glaxo Group Ltd Heterocyclic compounds
HU895334D0 (en) * 1986-07-30 1990-01-28 Sandoz Ag Process for the preparation of nasal pharmaceutical compositions

Also Published As

Publication number Publication date
IL84844A0 (en) 1988-06-30
DK662787A (da) 1988-06-18
GB8630071D0 (en) 1987-01-28
ATE79031T1 (de) 1992-08-15
JPS63165314A (ja) 1988-07-08
US4835173A (en) 1989-05-30
DK662787D0 (da) 1987-12-16
JP2732844B2 (ja) 1998-03-30
IE873415L (en) 1988-06-17
EP0276559A3 (en) 1989-10-18
NZ222949A (en) 1997-06-24
PH25503A (en) 1991-07-24
ES2051754T3 (es) 1994-07-01
DE3780940T2 (de) 1992-12-24
EP0276559B1 (en) 1992-08-05
KR880007073A (ko) 1988-08-26
IE60135B1 (en) 1994-06-01
EP0276559A2 (en) 1988-08-03
AU608794B2 (en) 1991-04-18
ZA879458B (en) 1988-11-30
CY1693A (en) 1994-01-14
DE3780940D1 (de) 1992-09-10
HK36593A (en) 1993-04-23
AU8261787A (en) 1988-06-23

Similar Documents

Publication Publication Date Title
GR3005682T3 (enExample)
SE8503680L (sv) Indolderivat
MX9707570A (es) Utilizacion de agonistas de alta1l para el tratamiento de la incontinencia urinaria.
EP0363415A4 (en) Compounds for the treatment of alzheimer's disease
EP0786995A4 (enExample)
OA09194A (en) "Insecticidal treatment and compositions therefor".
IE873414L (en) Medicament for dementia
GR3004252T3 (enExample)
FI896306A7 (fi) Miesten yksinkertainen, pakattu inkontinenssisuojus
ZA855224B (en) Pyrrol-1-ylphenyldihydropyridazinones,their preparation and their use
AP9200355A0 (en) "Therapeutic agent"
ZA796789B (en) Novel 3,4-diaza-bicyclo (4.1.0) hept-2-en-5-ones, their preparation, and therapeutic agents containing these compounds
NO921086D0 (no) Fremgangsmaate for fremstilling og anvendelse av substituerte 2',3'-didesoksy-5-trifluormetyluridiner
EP0401262A4 (en) 24r-scymnol, and preparation and use thereof
IE873231L (en) Medicaments
EP0317913A3 (en) Di(meth)acrylates, process for their preparation and their use
GR74782B (enExample)
GR3034688T3 (en) Use of 6,7-substituted-2-aminotetralines for preparing pharmaceutical compositions useful for the treatment of septic shock, and antipyretic and antiinflammatory pharmaceutical compositions
EP0092386A3 (en) Hydantoin therapeutic agents
ZA874878B (en) Pyran derivatives
NZ223203A (en) Herbicidal compositions containing tetrahydrophthalimides and 1,3,5-triazin-2-yl-urea derivatives
李虎容 et al. OCCLUSAL CONSIDERATION FOR IMPLANTS
FI882378A7 (fi) Tandlaekarens patientstol.
CS310487A1 (en) Connection for amplifier's output stage's transistor operating point adjustment
CS754186A1 (en) Aid for medical instruments' introduction